These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3856312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraro N.
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [Abstract] [Full Text] [Related]

  • 6. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
    Caranobe C, Sié P, Fernandez F, Pris J, Moatti S, Boneu B.
    Thromb Haemost; 1984 Jul 29; 51(3):349-53. PubMed ID: 6593892
    [Abstract] [Full Text] [Related]

  • 7. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P, Cortelazzo S, Bassan R, Barbui T.
    Thromb Haemost; 1982 Oct 29; 48(2):125-6. PubMed ID: 6184841
    [Abstract] [Full Text] [Related]

  • 8. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 29; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 9. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
    Caranobe C, Sie P, Nouvel C, Laurent G, Pris J, Boneu B.
    Scand J Haematol; 1980 Oct 29; 25(4):289-95. PubMed ID: 7209398
    [Abstract] [Full Text] [Related]

  • 10. Platelet function in patients with high platelet counts.
    Ginsburg AD.
    Ann Intern Med; 1975 Apr 29; 82(4):506-11. PubMed ID: 1054537
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S, Davis JL, Walsh PN, Gardner FH.
    Arch Intern Med; 1978 Aug 29; 138(8):1251-3. PubMed ID: 277084
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA, Berndt MC, Booth W, Gregory C, Bull H, Greaves M.
    Thromb Res; 1982 Sep 01; 27(5):601-9. PubMed ID: 6960545
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B, Nouvel C, Sie P, Caranobe C, Combes D, Laurent G, Pris J, Bierme R.
    Scand J Haematol; 1980 Sep 01; 25(3):214-20. PubMed ID: 7466310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M.
    Acta Haematol Pol; 1992 Sep 01; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract] [Full Text] [Related]

  • 19. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
    Takayama H, Okuma M, Kanaji K, Sugiyama T, Sensaki S, Uchino H.
    Prostaglandins Leukot Med; 1983 Nov 01; 12(3):261-72. PubMed ID: 6318227
    [Abstract] [Full Text] [Related]

  • 20. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay.
    Koch CA, Lasho TL, Tefferi A.
    Br J Haematol; 2004 Oct 01; 127(1):34-9. PubMed ID: 15384975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.